Join
Live feed
·
PRReleasevia Quantisnow
Qiagen N.V. logo

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

ByQuantisnow·Wall Street's wire, on your screen.
QGEN· Qiagen N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QGEN (Qiagen N.V.) and more on Quantisnow.